Time slot's time in Taipei (GMT+8)
- 2024/2/24
- Room ACS Hall 203
- TAMIS-TSLA Joint Session
Roles of non-statin treatment in CAD with dyslipidemia patients
- TIME
- TOPIC
- SPEAKER
- MODERATOR
- 13:01-13:13
- Roles of PCSK-9 pathway inhibitors (antibody, inclisiran) in CAD
- SPEAKER:
林宗憲(Tsung-Hsien LIN)
Taiwan (台灣)
- MODERATOR:
林佳濱(Chia-Pin LIN)
Taiwan (台灣)
- 林宗憲(Tsung-Hsien LIN)
- Kaohsiung Medical University Chung-Ho Memorial Hospital